Scleroderma-related interstitial lung disease.

Respir Med Case Rep

Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Louisville Health Sciences Center, Louisville, KY, USA.

Published: July 2017

Scleroderma-related interstitial lung disease (SSc-ILD) is a pulmonary fibrosing disorder characterized by systemic inflammation and progressive scarring of the lungs that leads to respiratory failure. Although certain immunosuppressive therapies may slow disease progression, current treatment strategies are not curative; consequently, SSc-ILD continues to be a major cause of morbidity and mortality. We present four cases of SSc-ILD that emphasize the importance of early screening and detection, close follow-up, and aggressive management. We also highlight the need for well-conducted clinical trials designed to identify new and effective treatments.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524221PMC
http://dx.doi.org/10.1016/j.rmcr.2017.07.007DOI Listing

Publication Analysis

Top Keywords

scleroderma-related interstitial
8
interstitial lung
8
lung disease
8
disease scleroderma-related
4
disease ssc-ild
4
ssc-ild pulmonary
4
pulmonary fibrosing
4
fibrosing disorder
4
disorder characterized
4
characterized systemic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!